Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduction of corticosteroid use in outpatient treatment of acute exacerbation of COPD
2017-004872-76Phase 4Completed
- Sponsor
- Kantonsspital Baselland
- Start
- Apr 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of prednisone in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Kantonsspital Baselland. Primary endpoint: Time to next exacerbation. Started Apr 2020; status: completed.
02
Drugs
prednisone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2017-004872-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004872-76.